Oesophageal Cancer Trial, Recruiting NCT07004634 Sponsor: Ruijin Hospital Condition: Oesophageal Cancer
Back to Oesophageal Cancer

Oesophageal Cancer Trial, Recruiting

NCT07004634
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 years or older
  • People who have been diagnosed with esophageal cancer (confirmed through laboratory testing of tissue) and whose treatment plan requires a specific type of surgery involving three separate cuts — in the neck, chest, and abdomen
  • People who have been assessed as being in reasonably good overall physical health before surgery, based on a standard medical rating scale (ASA class I–III)

Who may not be able to join:

  • People who have a history of ongoing (chronic) pain or who have been taking pain-relief medications regularly before surgery
  • People with serious heart or lung problems (for example, significantly reduced lung function, such as a breathing test result below a certain threshold)
  • People who have a blood clotting disorder, or who are having this surgery as a repeat (redo) operation
  • People where, during the operation itself, the surgical team finds complications such as extensive scarring around the lungs, or a need to remove nearby organs — or any other situation where the medical team leading the trial decides that participation is not appropriate (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Hecheng Li, PhD, MD, Ruijin Hospital

Phone: 00862164370045

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
30 April 2025
Est. completion
1 May 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Postoperative Pain Scores

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov